Clinical Trials

162 studies in Hematology

  1. Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer
    1. Minnesota
  2. A Double Blind Placebo-Controlled Trial of Eflornithine and Sulindac to Prevent Recurrence of High Risk Adenomas and Second Primary Colorectal Cancers in Patients With Stage 0-III Colon Cancer, Phase III - Preventing Adenomas of the Colon With Eflornithine and Sulindac (PACES)
    1. Minnesota
  3. Randomized Phase III Trial of Lenalidomide Versus Observation Alone in Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma
    1. Minnesota
  4. MC1351: PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)
    1. Arizona,
    2. Florida,
    3. Minnesota
  5. S1304, A Phase II Randomized Study Comparing Two Doses of Carfilzomib (NSC-756640) With Dexamethasone for Multiple Myeloma Patients With Relapsed or Refractory Disease
    1. Florida
  6. A Phase II/III Trial of Neoadjuvant FOLFOX, With Selective Use of Combined Modality Chemoradiation Versus Preoperative Combined Modality Chemoradiation for Locally Advanced Rectal Cancer Patients Undergoing Low Anterior Resection With Total Mesorectal Excision
    1. Minnesota
  7. A Prospective Observational Study of Treatment Patterns and Effectiveness and Safety Outcomes in Advanced Basal Cell Carcinoma and Basal Cell Carcinoma Nevus Syndrome Patients
    1. Arizona,
    2. Florida
  8. A Phase 1/2 Dose Escalation Study to Determine the Safety, Pharmacokinetics, and Pharmacodynamics of Intravenous TKM-080301 in Patients With Advanced Solid Tumors
    1. Arizona,
    2. Minnesota
  9. Neuroblastoma Biology Studies
    1. Minnesota
  10. Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients With High-Risk, Hormone Receptor-Positive and HER2/Neu Negative Breast Cancer
    1. Minnesota
  1. Prev
  2. 4
  3. 5
  4. 6
  5. 7
  6. 8
  7. Next